Acta Med. 2004, 47: 101-105

https://doi.org/10.14712/18059694.2018.72

Does Neoplastic Cholecystokinin Expression Reflect the Embryonal Pattern of the Protein? A Study in Human Pancreas

Demetrio Tamiolakisa, Ioannis Venizelosb, Constantine Simopoulosc, Maria Lambropouloud, Athanasia Kotinie, Theodoros Jivannakisf, George Alexiadisd, Panagiotis Bogloud, Nikolas Papadopoulosd

aGeneral Hospital of Chania, Department of Cytology, Greece
bIppokration Hospital of Salonica, Department of Pathology, Greece
cDemocritus University of Thrace, Department of Experimental Surgery, Greece
dDemocritus University of Thrace, Department of Histology–Embryology, Greece
eDemocritus University of Thrace, Department of Medical Physics, Greece
fGeneral Hospital of Drama, Department of Pathology, Greece

Received January 1, 2004
Accepted February 1, 2004

References

1. Beinfeld MC. Cholecystokinin in the central nervous system: a minireview. Neuropeptides 1983; 3(6):411–27. <https://doi.org/10.1016/0143-4179(83)90032-X>
2. Cohen SM, Ellwein LB. Cell proliferation in carcinogenesis. Science 1990; 249:1007–11. <https://doi.org/10.1126/science.2204108>
3. Dockray GJ. Immunochemical evidence of cholecystokinin-like peptides in brain. Nature 1976; 264(5586):568–70. <https://doi.org/10.1038/264568a0>
4. Dockray GJ, Gregory RA, Hutchison RA, Harris JB, Runswick MJ. Isolation, structure and biological activity of two cholecystokinin octapeptides from sheep brain. Nature 1978; 274(5672):711–3. <https://doi.org/10.1038/274711a0>
5. Dockray GJ. The physiology of cholecystokinin in brain and gut. Br Med Bull 1982; 38(3):253–8. <https://doi.org/10.1093/oxfordjournals.bmb.a071769>
6. Douglas BR, Wouterson RA, Jansen JB, DeJong AJ. Influence of cholecystokinin and bombesin on azaserine induced lesions in the rat pancreas. Gastroenterology 1989; 96:462–9. <https://doi.org/10.1016/0016-5085(89)91572-2>
7. Escribano MJ, Cordier J, Nap M, Ten F, Kate, Burtin P. Differentiation antigens in fetal human pancreas. Re-expression in cancer. Int J Cancer 1986; 38:155–60. <https://doi.org/10.1002/ijc.2910380202>
8. Folsch UR, Winckler K, Wormsley KG. Influence of repeated administration of cholecystokinin and secretin on the pancreas of the rat. Scand J Gastroenterol 1978; 13:663–71. <https://doi.org/10.3109/00365527809181779>
9. Hall PA, Lemoine NR. Rapid acinar to ductal transdifferentiation in cultured human exocrine pancreas. J Pathol 1992; 166:97–103. <https://doi.org/10.1002/path.1711660203>
10. Hall PA, Lemoine NR. Models of pancreatic cancer. Cancer Surv 1993; 16:135–55.
11. Herrington MK, Adrian TE. On the role of cholecystokinin in pancreatic cancer. Int J Pancreatol 1995; 17:121–38.
12. Hoosein NM, Keiner PA, Curry RC, Brattain MG. Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide. Exp Cell Res 1990; 186: 15–21. <https://doi.org/10.1016/0014-4827(90)90204-N>
13. Howatson AG, Carter DC. Pancreatic carcinogenesis enhancement by cholecystokinin in the hamster nitrosamine model. Br J Cancer 1985; 51:107–14. <https://doi.org/10.1038/bjc.1985.15> <PubMed>
14. Hudd C, LaRegina MC, Devine. Response to exogenous cholecystokinin of six human gastrointestinal cancers xenografted in nude mice. Am J Surg 1989; 157:386–94. <https://doi.org/10.1016/0002-9610(89)90582-5>
15. Iovanna JL, de la Porte PL, Dagorn JC. Expression of genes associated with dedifferentiation and cell proliferation during pancreatic regeneration following acute pancreatitis. Pancreas 1992; 7:712–8. <https://doi.org/10.1097/00006676-199211000-00013>
16. Kalser MH, Ellenberg SS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985; 120:899–903.
17. Kersterns PJ, Lamers CB, Jansen JB, de Jong AJ, Hessels M, Hafkensheid JC. Physiological plasma concentrations of cholecystokinin stimulate pancreatic enzyme secretion and gallbladder contraction in man. Life Sci 1985; 36(6): 565–9. <https://doi.org/10.1016/0024-3205(85)90638-1>
18. Kloppel G, Heitz PU. Pancreatic endocrine tumors. Pathol Res Pract 1988; 183: 155–68. <https://doi.org/10.1016/S0344-0338(88)80043-8>
19. Le Meuth, V, Philouze-Rome V, et al. Differential expression of the A- and B-subtypes of the cholecystokinin/gastrin receptors in the developing calf pancreas. Endocrinology 1993; 133: 1182–91. <https://doi.org/10.1210/endo.133.3.8365360>
20. Logsdon CD. Pancreatic duct cell cultures: there is more to ducts than salty water. Gastroenterology 1995; 109:1005–9. <https://doi.org/10.1016/0016-5085(95)90415-8>
21. Mainz DL, Black O, Webster PD. Hormonal control of pancreatic growth. J Clin Invest 1973; 52:2300–4. <https://doi.org/10.1172/JCI107418> <PubMed>
22. Matsumori Y, Katakami N, Ito M, Taniguchi T, Iwata N, Takaishi T. Cholecystokinin- B/gastrin receptor: a novel molecular probe for human small cell lung cancer. Cancer Res 1995; 55:276–9.
23. Miller BA, Ries LAG, Hankey BF, Kosary CL, Edwards BK. Cancer Statistics Review: 1973–1989. National Cancer Institute. NIH Publication 1992;92: 2789.
24. Monstein HJ, Nylander AG, Salehi A, Chen D, Lundquist I, Hakanson R. Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. Scand J Gastroenterol 1996; 31:383–90. <https://doi.org/10.3109/00365529609006415>
25. Morley JE. Minireview. The ascent of chelecystokinin (CCK)-from gut to brain. Life Sci 1982; 30(6):479–93. <https://doi.org/10.1016/0024-3205(82)90261-2>
26. Mutt V. Chemistry, isolation and purification of gastrointestinal hormones. In: Gastrointestinal Hormones. Glass, G.B.J.;Ed.; Raven Press: New York, 1980: pp.169.
27. Povoski SP, Zhou W, Longnecker DS, Bell R. Cholecystokinin receptor characterization and cholecystokinin-A receptor mRNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas. Oncol Res 1994; 6:411–7.
28. Povoski SP, Zhou W, Longnecker DS, Jensen RT, Mantey SA, Bell RH. Stimulation of in vivo pancreatic growth in the rat is mediated specifically by way of cholecystokinin A receptors. Gastroenterology 1994; 107:1135–46. <https://doi.org/10.1016/0016-5085(94)90239-9>
29. Rehfeld JF. Neuronal cholecystokinin: one or multiple transmitters? Neurochem 1985; 44(1): 1–10. <https://doi.org/10.1111/j.1471-4159.1985.tb07105.x>
30. Rehfeld JF, van Solinge WW. The tumor biology of gastrin and cholecystokinin. Adv Cancer Res 1994; 63:295–347. <https://doi.org/10.1016/S0065-230X(08)60403-0>
31. Smith JP, Framer ST, Solomon TE. CCK stimulates the growth of six human pancreatic cancer cell lines in serum free medium. Regul Pep 1991; 32:341–9. <https://doi.org/10.1016/0167-0115(91)90027-E>
32. Steele GD, Osteen RT, Winchester DP, Menck HR, Murphy GP. National Cancer Data Base Annual Review of Patient Care. American Cancer Society Publication 54, 1994.
33. Steigerwalt RW, Williams JA. Binding specificity of the mouse cerebral cortex receptor for small cholecystokinin peptides. Regul Pept 1984; 8(1):51–9. <https://doi.org/10.1016/0167-0115(84)90028-4>
34. Zhou W, Povoski S, Bell RH. Overexpression of messenger RNA for the cholecystokinin- A receptor and novel expression of messenger RNA for gastrin (cholecystokinin- B) receptor in azaserine induced rat pancreatic carcinoma. Carcinogenesis 1993; 14:2189–92. <https://doi.org/10.1093/carcin/14.10.2189>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive